🇺🇸 Hemabate in United States

609 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Vomiting — 105 reports (17.24%)
  2. Nausea — 103 reports (16.91%)
  3. Off Label Use — 80 reports (13.14%)
  4. Diarrhoea — 58 reports (9.52%)
  5. Chest Discomfort — 53 reports (8.7%)
  6. Abdominal Pain Upper — 49 reports (8.05%)
  7. Blood Pressure Increased — 46 reports (7.55%)
  8. Dyspnoea — 46 reports (7.55%)
  9. Abdominal Discomfort — 40 reports (6.57%)
  10. Abdominal Pain — 29 reports (4.76%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Hemabate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hemabate in United States?

Dongyu Wang is the originator. The local marketing authorisation holder may differ — check the official source linked above.